Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MARIO ERNEST
Soleno Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vivo Opportunity Fund Holdings, L.P.(22.5%),Vivo Opportunity, LLC(22.5%)
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Vivo Opportunity, LLC
Soleno Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Manning Meredith
Soleno Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Huang Michael F.
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yen Kristen
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mackaness James H
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hirano Patricia C
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Anish Bhatnagar
Soleno Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(2.3%),Commodore Capital Master LP(2.3%)
Soleno Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%), etc.
Soleno Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(8.3%),Janus Henderson Biotech Innovation Master Fund Ltd(2.7%)
Soleno Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(5.99%),Adage Capital Partners GP, L.L.C.(5.99%), etc.
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yen Kristen
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hirano Patricia C
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Anish Bhatnagar
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MARIO ERNEST
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yen Kristen
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mackaness James H
Soleno Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hirano Patricia C
No Data